| Literature DB >> 33990893 |
Şerif Bora Nazlı1, Fatih Yığman2, Muhammet Sevindik3, Deniz Deniz Özturan4.
Abstract
BACKGROUND: Vaccine hesitancy is an important public health problem. AIMS: Identifying and understanding COVID-19 vaccine hesitancy may aid future public health messaging. This study, in which we planned to study the determinants of COVID-19 vaccine hesitancy, aims to reveal the relationship between "intolerance of uncertainty," "belief in conspiracy theories," and "COVID-19 phobia" with vaccine hesitancy.Entities:
Keywords: COVID-19 phobia; COVID-19 vaccine; Conspiracy theories; Vaccine hesitancy
Mesh:
Substances:
Year: 2021 PMID: 33990893 PMCID: PMC8121491 DOI: 10.1007/s11845-021-02640-0
Source DB: PubMed Journal: Ir J Med Sci ISSN: 0021-1265 Impact factor: 1.568
Some descriptive characteristics of the participants
| ( | |
|---|---|
| Age (years), mean ± SD (min–max) | 35.8 ± 9.1 (18–67) |
| Gender, | |
| Male | 206 (44.1) |
| Female | 261 (55.9) |
| Marital status, | |
| Married | 295 (63.2) |
| Single | 161 (34.5) |
| Other | 11 (2.4) |
| Child status, | |
| Yes | 244 (52.2) |
| No | 223 (47.8) |
| Number of children of those with children ( | 1.7 ± 0.8 (1–4) |
| Profession, | |
| Physician | 180 (38.5) |
| Teacher | 46 (9.9) |
| Assistant healthcare personnel | 44 (9.4) |
| Pharmaceutical representative | 26 (5.6) |
| Housewife | 20 (4.3) |
| Engineer | 19 (4.1) |
| School student | 14 (3.0) |
| Dentist | 13 (2.8) |
| Faculty member | 12 (2.6) |
| Not working | 11 (2.4) |
| Other | 82 (17.6) |
| Previous COVID-19 experience | |
| Yes | 80 (17.1) |
| No | 387 (82.9) |
| Treatments administered to COVID-19 patients ( | |
| Outpatient treatment | 75 (93.8) |
| Inpatient treatment in hospital | 3 (3.8) |
| Inpatient treatment in ICU | 2 (2.5) |
| COVID-19 experience of a first-degree relative | |
| Yes | 173 (37.0) |
| No | 294 (63.0) |
| Death of a first-degree relative or close friend due to COVID-19 | |
| Yes | 63 (13.5) |
| No | 404 (86.5) |
n number of individuals, % percent, mean mean, SD standard deviation
Attitudes of participants towards COVID-19 vaccine
| ( | |
|---|---|
| Attitude towards COVID-19 vaccine | |
| Trusts the positive effects of the vaccine and wants to get vaccinated | 206 (44.1) |
| Unsure about the positive effects of the vaccine but wants to get vaccinated | 191 (40.9) |
| Unsure about the positive effects of the vaccine and does not want to get vaccinated | 41 (8.8) |
| Thinks the vaccine will have negative effects/will be ineffective and does not want to get vaccinated | 29 (6.2) |
n number of individuals, % percent
Scores of the scales applied to participants
| ( | Mean ± SD (min–max) |
|---|---|
| COVID-19 Phobia Scale | |
| Anxiety | 33.5 ± 8.5 (10–50) |
| Reassurance seeking/precaution | 24.6 ± 4.9 (7–35) |
| Mood | 8.3 ± 2.9 (3–15) |
| Avoidance | 8.2 ± 1.7 (2–10) |
| Total | 74.5 ± 15.5 (22–110) |
| Intolerance of Uncertainty Scale 12 (IUS-12) | |
| Prospective anxiety | 23.2 ± 5.4 (7–35) |
| Debilitating anxiety | 15.2 ± 5.0 (5–25) |
| Total | 38.4 ± 9.7 (12–60) |
| Conspiracy Mentality Scale (CMS) | 34.0 ± 8.8 (0–50) |
| Vaccine Conspiracy Beliefs Scale (VCBS) | 21.2 ± 12.6 (0–50) |
n number of individuals, mean mean, SD standard deviation, IUS Intolerance of Uncertainty Scale, CMS Conspiracy Mentality Scale, VCBS Vaccine Conspiracy Beliefs Scale
Distribution of some descriptive characteristics of participants according to their attitudes towards COVID-19 vaccine
| Attitude towards COVID-19 vaccine | |||||
|---|---|---|---|---|---|
| Group I ( | Group II ( | Group III ( | Group IV ( | ||
| Age (years), mean ± SD (min–max) | 36.9 ± 8.6 (22–65) | 35.8 ± 9.3 (19–67) | 32.5 ± 9.5 (18–61) | 32.0 ± 8.0 (21–47)a | 0.003* |
| Gender, | |||||
| Male | 110 (53.4) | 65 (34.0) | 18 (43.9) | 13 (44.8) | 0.002* |
| Female | 96 (46.6) | 126 (66.0) | 23 (56.1) | 16 (55.2) | |
| Marital status, | |||||
| Married | 137 (66.5) | 124 (64.9) | 21 (51.2) | 13 (44.8) | 0.224 |
| Single | 65 (31.6) | 62 (32.5) | 19 (46.3) | 15 (51.7) | |
| Other | 4 (1.9) | 5 (2.6) | 1 (2.4) | 1 (3.4) | |
| Child presence, | 117 (56.8) | 100 (52.4) | 16 (39.0) | 11 (37.9) | 0.073 |
| Number of children of those with children, mean ± SD (min–max) | 1.7 ± 0.8 (1–4) | 1.7 ± 0.7 (1.4) | 2.2 ± 1.1 (1–4) | 1.7 ± 0.6 (1–3) | 0.337 |
| Previous COVID-19 experience | 36 (17.5) | 28 (14.7) | 8 (19.5) | 8 (27.6) | 0.357 |
| Treatments administered to COVID-19 patients | |||||
| Outpatient treatment | 34 (94.4) | 27 (96.4) | 6 (75.0) | 8 (100) | 0.127 |
| Inpatient treatment | 2 (5.6) | 1 (3.6) | 2 (25.0) | 0 | |
| COVID-19 experience of a first degree relative | 76 (36.9) | 71 (37.2) | 16 (39.0) | 10 (34.5) | 0.985 |
| Death of a first degree relative or close friend due to COVID-19 | 18 (8.7) | 30 (15.7) | 7 (17.1) | 8 (27.6) | 0.017* |
n number of individuals, % column percentage, mean mean, SD standard deviation, Group I trusts the positive effects of the vaccine and wants to get vaccinated, Group II unsure about the positive effects of the vaccine but wants to get vaccinated, Group III unsure about the positive effects of the vaccine and does not want to get vaccinated, Group IV thinks the vaccine will have negative effects/will be ineffective and does not want to get vaccinated
*p < 0.05
aPost hoc paired comparison revealed a significant difference with the “group I” group
Distribution of scores of scales applied among participants’ attitudes towards COVID-19 vaccine
| Attitude towards COVID-19 Vaccine | |||||||
|---|---|---|---|---|---|---|---|
| Group-I ( | Group-II ( | Group-III ( | Group-IV ( | ||||
| COVID-19 Phobia Scale | |||||||
| Anxiety | 33.3±8.3 (10-50) | 34.9±7.9 (12-50) | 30.3±10.1 (10-49) | 29.9±9.8 (10-47) | 0.007* | ||
| Reassurance seeking | 24.5±4.6 (7-35) | 25.5±4.4 (10-35) | 22.8±5.7 (10-33) | 21.0±6.6 (7-35) | <0.001* | ||
| Mood | 8.1±2.8 (3-15) | 8.6±2.9 (3-15) | 8.0±3.1 (3-14) | 7.7±3.4 (3-14) | 0.208 | ||
| Avoidance | 8.2±1.6 (2-10) | 8.3±1.6 (2-10) | 8.2±1.6 (4-10) | 7.2±2.2 (2-10) | 0.058 | ||
| Total | 74.2±14.7 (22-110) | 77.3±14.1 (34-108) | 69.4±18.5 (35-104) | 65.8±20.0 (22-98) | 0.002* | ||
| IUS-12 | |||||||
| Prospective anxiety | 22.7±5.6 (7-35) | 23.8±5.1 (8-35) | 22.9±5.0 (11-33) | 22.8±6.2 (7-35) | 0.361 | ||
| Debilitating anxiety | 14.8±4.8 (5-25) | 15.8±5.0 (5-25) | 15.1±5.4 (5-25) | 14.9±5.3 (5-22) | 0.231 | ||
| Total | 37.4±9.8 (12-60) | 39.6±9.4 (14-60) | 38.0±9.5 (18-56) | 37.7±10.6 (12-56) | 0.229 | ||
| CMS | 31.8±8.7 (0-50) | 35.3±7.9 (9-50) | 37.6±9.2 (13-50) | 36.8±10.3 (9-50) | <0.001* | ||
| VCBS | 15.5±11.2 (0-50) | 24.1±11.0 (0-50) | 27.4±11.5 (0-50) | 34.4±12.6 (0-50) | <0.001* | ||
Variables were presented as “mean ± standard deviation (minimum–maximum)”
n number of individuals, IUS Intolerance of Uncertainty Scale, CMS Conspiracy mentality scale, VCBS Vaccine Conspiracy Beliefs Scale, Group I trusts the positive effects of the vaccine and wants to get vaccinated, Group II unsure about the positive effects of the vaccine but wants to get vaccinated, Group III unsure about the positive effects of the vaccine and does not want to get vaccinated, Group IV thinks the vaccine will have negative effects/will be ineffective and does not want to get vaccinated
*p < 0.05
The relationship between the scales applied to the participants
| ( | Age | IUS-12 | CMS | VCBS | ||
|---|---|---|---|---|---|---|
| Prospective Anxiety | Debilitating Anxiety | Total | ||||
| COVID-19 PHOBIA | ||||||
| Anxiety | 0.038 | 0.384** | 0.370** | 0.404** | 0.150** | 0.173** |
| Reassurance Seeking | 0.139** | 0.316** | 0.299** | 0.331** | 0.137** | 0.208** |
| Mood | –0.007 | 0.375** | 0.345** | 0.387** | 0.111* | 0.113* |
| Avoidance | 0.124** | 0.306** | 0.267** | 0.309** | 0.141** | 0.027 |
| Total | 0.072 | 0.421** | 0.405** | 0.444** | 0.166** | 0.188** |
| IUS-12 | ||||||
| Prospective Anxiety | –0.032 | 1.000 | 0.717** | 0.923** | 0.238** | 0.203** |
| Debilitating Anxiety | –0.057 | 0.717** | 1.000 | 0.925** | 0.212** | 0.255** |
| Total | –0.047 | 0.923** | 0.925** | 1.000 | 0.242** | 0.244** |
| CMS | –0.028 | 0.238** | 0.212** | 0.242** | 1.000 | 0.465** |
| VCBS | 0.044 | 0.203** | 0.255** | 0.244** | 0.465** | 1.000 |
Variables are presented with Spearman’s correlation coefficient
n number of individuals, IUS Intolerance of Uncertainty Scale, CMS Conspiracy Mentality Scale, VCBS Vaccine Conspiracy Beliefs Scale
*p < 0.05; **p < 0.01